YOUR FORESIGHT. HIS FUTURE.

The first NOAC with
a reversal agent

YOUR FORESIGHT.
HIS FUTURE.

AF Guidelines , Appropriate NOAC dosing based on Co morbidities and Clinical Practice - Prof. Jan Steffel (Tiếng Anh)

Document ID: PC-VN-101399

07/04/2022

Author: Boehringer Ingelheim

Related content

PC-VN-101399
Production date: April 2022